PL2087893T3 - Zawierające alprazolam kompozycje do leczenia bezsenności pierwotnej i bezsenności związanej ze stanami lękowymi oraz sposoby wytwarzania tych kompozycji - Google Patents
Zawierające alprazolam kompozycje do leczenia bezsenności pierwotnej i bezsenności związanej ze stanami lękowymi oraz sposoby wytwarzania tych kompozycjiInfo
- Publication number
- PL2087893T3 PL2087893T3 PL08002077T PL08002077T PL2087893T3 PL 2087893 T3 PL2087893 T3 PL 2087893T3 PL 08002077 T PL08002077 T PL 08002077T PL 08002077 T PL08002077 T PL 08002077T PL 2087893 T3 PL2087893 T3 PL 2087893T3
- Authority
- PL
- Poland
- Prior art keywords
- insomnia
- alprazolam
- compositions
- preparing
- processes
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
- A61K31/5517—1,4-Benzodiazepines, e.g. diazepam or clozapine condensed with five-membered rings having nitrogen as a ring hetero atom, e.g. imidazobenzodiazepines, triazolam
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
- A61K9/006—Oral mucosa, e.g. mucoadhesive forms, sublingual droplets; Buccal patches or films; Buccal sprays
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/2027—Organic macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. polyvinyl pyrrolidone, poly(meth)acrylates
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2022—Organic macromolecular compounds
- A61K9/205—Polysaccharides, e.g. alginate, gums; Cyclodextrin
- A61K9/2054—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2095—Tabletting processes; Dosage units made by direct compression of powders or specially processed granules, by eliminating solvents, by melt-extrusion, by injection molding, by 3D printing
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Physiology (AREA)
- Nutrition Science (AREA)
- Neurosurgery (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Anesthesiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP08002077A EP2087893B1 (en) | 2008-02-05 | 2008-02-05 | Compositions comprising alprazolam for treating primary insomnia and insomnia associated with anxiety states and processes for preparing them |
Publications (1)
Publication Number | Publication Date |
---|---|
PL2087893T3 true PL2087893T3 (pl) | 2013-07-31 |
Family
ID=39284731
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PL08002077T PL2087893T3 (pl) | 2008-02-05 | 2008-02-05 | Zawierające alprazolam kompozycje do leczenia bezsenności pierwotnej i bezsenności związanej ze stanami lękowymi oraz sposoby wytwarzania tych kompozycji |
Country Status (4)
Country | Link |
---|---|
US (2) | US20090197873A1 (pl) |
EP (1) | EP2087893B1 (pl) |
ES (1) | ES2403193T3 (pl) |
PL (1) | PL2087893T3 (pl) |
Families Citing this family (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2020121027A1 (es) * | 2018-12-12 | 2020-06-18 | Laboratorios Bagó S.A. | Composiciones de alprazolam amorfo con actividad ansiolítica, con etilcelulosa y crospovidona, y procedimientos correspondientes |
US10898493B2 (en) | 2019-04-12 | 2021-01-26 | LA PharmaTech Inc. | Pharmaceutical compositions and methods for psychiatric symptoms of patients with Alzheimer's disease |
US11938139B2 (en) | 2019-04-12 | 2024-03-26 | LA PharmaTech Inc. | Pharmaceutical compositions and methods for anxiety, depression and other psychiatric disorders |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3987052A (en) | 1969-03-17 | 1976-10-19 | The Upjohn Company | 6-Phenyl-4H-s-triazolo[4,3-a][1,4]benzodiazepines |
ATE60226T1 (de) * | 1986-03-10 | 1991-02-15 | Kurt Burghart | Pharmazeutikum sowie verfahren zu seiner herstellung. |
DE4327063A1 (de) | 1993-08-12 | 1995-02-16 | Kirsten Dr Westesen | Ubidecarenon-Partikel mit modifizierten physikochemischen Eigenschaften |
US20040141923A1 (en) | 1997-10-01 | 2004-07-22 | Dugger Harry A. | Buccal, polar and non-polar spray containing alprazolam |
AR032585A1 (es) | 2000-05-19 | 2003-11-19 | Bago Sa Labor | Procedimiento para preparar composiciones farmaceuticas en comprimidos de desintegracion rapida sustancialmente exentos de cristales del principio farmacologicamente activo provenientes de la modificacion de la estructura cristalina de dicho agente durante las operaciones de fabricacion de los mismo |
GB0106601D0 (en) | 2001-03-16 | 2001-05-09 | Unilever Plc | Antiperspirant formulations |
ATE415155T1 (de) | 2001-05-24 | 2008-12-15 | Alexza Pharmaceuticals Inc | Verabreichung von alprazolam, estazolam, midazolam oder triazolam durch inhalation |
BR0302017B1 (pt) * | 2003-06-02 | 2014-10-29 | Ems Sigma Pharma Ltda | Composição farmacêutica sublingual a base de um agonista do receptor central de benzodiazepínicos |
AU2004287485A1 (en) * | 2003-11-05 | 2005-05-19 | Santarus, Inc. | Combination of proton pump inhibitor and sleep aid |
-
2008
- 2008-02-05 PL PL08002077T patent/PL2087893T3/pl unknown
- 2008-02-05 EP EP08002077A patent/EP2087893B1/en active Active
- 2008-02-05 ES ES08002077T patent/ES2403193T3/es active Active
-
2009
- 2009-02-02 US US12/363,802 patent/US20090197873A1/en not_active Abandoned
-
2013
- 2013-12-11 US US14/102,934 patent/US9308212B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
EP2087893A1 (en) | 2009-08-12 |
US20140107108A1 (en) | 2014-04-17 |
ES2403193T3 (es) | 2013-05-16 |
US9308212B2 (en) | 2016-04-12 |
US20090197873A1 (en) | 2009-08-06 |
EP2087893B1 (en) | 2013-02-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HRP20190214T1 (hr) | Pripravci i metode za liječenje purpure | |
IL239918A0 (en) | Preparations for the treatment of colitis | |
EP2271218A4 (en) | USE AND COMPOSITION FOR THE TREATMENT OF DEMENTIA | |
EP2322508A4 (en) | PROCESS FOR MANUFACTURING AGOMELATIN AND ITS INTERMEDIATE | |
EP2164996A4 (en) | RIBOREGULATORS AND METHODS AND COMPOSITION FOR THE USE OF AND WITH RIBOREGULATORS | |
EP2497482A4 (en) | COMPOSITION FOR PROPHYLAXIS AND TREATMENT OF INFLUENZA AVIRUSED INDUCED DISEASES | |
IL210097A0 (en) | Compositions and methods for treating unfluenza | |
EP2282719A4 (en) | COMPOSITIONS AND METHODS FOR TREATING MULTIPLE SCLEROSIS | |
EP2504428A4 (en) | METHOD AND COMPOSITIONS FOR TREATING OXALATE-MEDIATED SUFFERING | |
HK1162058A1 (en) | Tanning process and tanning composition | |
EP2355660A4 (en) | COMPOSITIONS AND METHODS FOR THE TREATMENT OF MULTIPLE SCLEROSIS | |
IL215932A0 (en) | Compositions and methods for treating burns | |
ZA201303136B (en) | Methods and composition for treating hiv-associated diarrhea | |
EP2340297A4 (en) | COMPOSITION, ITS MANUFACTURING METHOD AND USE | |
EP2485738A4 (en) | COMPOSITIONS AND METHOD FOR THE TREATMENT OF ADIPOSITAS | |
EP2340254A4 (en) | COMPOSITIONS AND METHODS FOR TREATING EPILEPSY | |
IL243809A0 (en) | Process for the production of γ-ketosulfide compound and γ-ketosulfide compounds | |
EP2139909A4 (en) | PREQ1-RIBOSWITCHES AND METHOD AND COMPOSITIONS FOR USE BY AND WITH PREQ1-RIBOSWITCHES | |
IL221809A (en) | Herbal preparation for the prevention and / or treatment of anxiety and related conditions | |
PL2087893T3 (pl) | Zawierające alprazolam kompozycje do leczenia bezsenności pierwotnej i bezsenności związanej ze stanami lękowymi oraz sposoby wytwarzania tych kompozycji | |
EP2512504A4 (en) | COMPOSITION AND THERAPEUTIC METHOD | |
ZA201105441B (en) | Ethanamine compounds and their use for treating depression | |
EP2209488A4 (en) | FGF9-ASSOCIATED METHODS FOR TREATING ANXIETY STATE | |
GB2500357B (en) | Combination and composition for treating obesity | |
IL217764A0 (en) | Methods and compositions for treating leukemia |